This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision |
| rop_oxygen_protocol [2025/09/29 18:59] – Scott Larson | rop_oxygen_protocol [2025/09/29 19:18] (current) – Scott Larson |
|---|
| {{:rop_oxygen_protocol.jpg|}} | {{:rop_oxygen_protocol.jpg|}} |
| ==== References ==== | ==== References ==== |
| * [[https://pubmed.ncbi.nlm.nih.gov/28159975/|Colaizy TT, Longmuir S, Gertsch K, Abramoff MD, Klein JM. Use of a Supplemental Oxygen Protocol to Suppress Progression of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2017;58(2):877-891 | * [[https://pubmed.ncbi.nlm.nih.gov/28159975/|Colaizy TT, Longmuir S, Gertsch K, Abramoff MD, Klein JM. Use of a Supplemental Oxygen Protocol to Suppress Progression of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2017;58(2):877-891]] |
| * [[https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-024-03483-w|Minturn R et al. Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity. BMC Ophthalmology 2024;24:220]] | * [[https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-024-03483-w|Minturn R et al. Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity. BMC Ophthalmology 2024;24:220]] |
| | * [[https://publications.aap.org/pediatrics/article/105/2/295/62563/Supplemental-Therapeutic-Oxygen-for-Prethreshold?autologincheck=redirected|Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A randomized, Controlled Trial. I: Primary Outcomes. The STOP-ROP Multicenter Study Group. Pediatrics 2000;105(2):295-310.]] |
| |
| {{tag>rop}} | {{tag>rop}} |